期刊文献+

表浅性膀胱癌预后与癌肿数目、病理分级的关系 被引量:2

Prognostic factors of primary superficial bladder cancer.
下载PDF
导出
摘要 目的探讨表浅性膀胱癌肿块数目、病理分级与患者预后的关系。方法对122例表浅性膀胱癌进行回顾性分析。结果122例中,40例术后复发,术后5年内的复发率为32.79%。初诊时肿瘤为多发者即3个及3个以上肿瘤、G3级的肿瘤术后复发的平均时间、5年内的复发率分别高于单发或双发者、G1或G2级的肿瘤。结论膀胱癌肿瘤数目、细胞分级是影响表浅性膀胱癌预后的重要因素,多发肿瘤、G3级肿瘤可能在较短时间内复发,及时行膀胱切除更为妥当。 Objective To study the prognostic factors of patients with primary superficial transitional cell bladder carcinoma. Methods Total of 122 cases with superficial transitional cell carcinoma of the bladder were reviewed. Results Forty of the 122 patients had tumor recurrence and the 5 - year recurrence rate was 32.79%. Cases with multiple tumors more than 3 and G3 grade tumors tended to have higher tumor recurrence rates than a single tumour or a double tumour and Gt or G2 grade turnouts. Conclusion The number of tumour and the grade of primary superficial transitional cell bladder carcinoma are the prognostic factors. High grade, multiple tumors more than 3 and G3 grade tumors have high tumor recurrence rates with great speed, better undergo cystectomy instantly.
出处 《现代肿瘤医学》 CAS 2006年第4期434-435,共2页 Journal of Modern Oncology
关键词 膀胱肿瘤 表浅性 预后 bladder neoplasms superficial bladder cancer prognosis
  • 相关文献

参考文献8

  • 1Rodriguez FM,Toniolo GC,Bayarri JS,et al.Multivaritc analysis of the prognostic factors of primary superficial bladder cancer[ J ].J Urol,2000,163 (1):73 ~78.
  • 2Thompson DJ,Campbell KW,Kramer HC,et al.Late invasive recurrence despite long term surveillance for superficial bladder cancer[J].J Urol,1993,149:1010 ~1012.
  • 3Sydransky D,Frost F,Von Eschenbach A,et al.Clonal origin of bladder cancer[ J].N Engl J Med,1992,326:737 ~740.
  • 4Chem HD,Becich MI,Persad RA,et al.Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of p53 and retinoblastoma proteins[J].J Urol,1998,156:1846 ~1849.
  • 5叶定伟,李慧,Peter Murphy,孙颖浩,钱松溪,郑家富,马永江.膀胱癌多发或复发的克隆起源[J].中华泌尿外科杂志,2000,21(5):280-281. 被引量:4
  • 6Kurth-K H.Intravesical chemotherapy for superficial bladder tumors calegray Ta/T1:Who should be treated and how[ J ].semin Urol Oncol,1996,14:30 ~ 35.
  • 7Honda Ⅳ,Yamada Y,Mitsui K,et al.Clinical study on recurrence in bladder cancer patients undergoing tofal cystectomy statistical analysis of factors related to recurrence[ J ].Hinyokika Kiyo,1999,45(5):317 324.
  • 8Gohji K,Nomi M,Okamoto M,et al.Concervative therapy for stage T1 b,Grade 3 transitional cell carcinoma of the bladder[ J ].Urology,1999,53(2):308 ~313.

二级参考文献3

  • 1Ye D,J Urol,1998年,160期,2025页
  • 2Michieli P,Cancer Res,1994年,54卷,3391页
  • 3Ye D,J Urol,1993年,150期,884页

共引文献3

同被引文献23

  • 1Willem O,Fred W,Sylvester RJ.Diagnostic and prognostic factors in non-muscle-invasive bladder cancer and their influence on treatment and outcomes[J].Eur Urol,2008,7(Suppl 7):516-523.
  • 2Louis R,Andrew C,Atan W,et al.Campbell-Walsh Urology[M].9th ed.USA:Elsevier Inc,2007(9):2447-2467.
  • 3Lokeshwar VB,Habuchi T,Grossman HB,et al.Bladder tumor markers beyond cytology:international consensus panel on bladder tumor markers[J].Urology,2005,66(Suppl 1):35-63.
  • 4Donat SM.Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer:strategy versus reality[J].J Natl Compr Canc Netw,2009,7(1):40-47.
  • 5Kubin A,Meissner P,Wierrani F,et al.Guidelines on TaT1(Non-muscle invasive) bladder cancer[J].Photochem Photobiol Sci,2008,84(6):1560-1563.
  • 6Fernandez-Gomez J,Solsona E,Unda M,et al.Prognostic factors in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin:multivariate analysis of data from four randomized CUETO trials[J].Eur Urol,2008,53(5):992-1001.
  • 7Sylvester RJ,van der Meijden AP,Oosterlinck W,et al.Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables:A combined analysis of 2596 patients from seven EORTC trials[J].Eur Urol,2006,49(3):466-477.
  • 8Orsola A,Trias I,Raventós CX,et al.Initial highgrade T1 urothelial cell carcinoma:feasibility and prognostic significance of lamina propria invasion microstaging(Tla/b/c)in BCG-treated and non-treated patients[J].Eur Urol,2005,48(2):231-238.
  • 9Stein JP,Penson DF,Wu SD,et al.Pathological guidelines for orthotopic urinary diversion in women with bladder cancer:A review of the literature[J].J Urol,2007,178(3):756-760.
  • 10Matthew RB,Andreas B,Michael A.Intravesical instillation treatment of non-muscle-invasive bladder cancer[J].Eur Urol,2009,8(Suppl 7):549-555.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部